- Home
- REAX vs EYPT Comparison
REAX vs EYPT Comparison
Compare REAX & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REAX
- EYPT
- Stock Information
- Founded
- REAX 2018
- EYPT 1987
- Country
- REAX United States
- EYPT United States
- Employees
- REAX N/A
- EYPT N/A
- Industry
- REAX
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- REAX
- EYPT Industrials
- Exchange
- REAX Nasdaq
- EYPT Nasdaq
- Market Cap
- REAX 820.5M
- EYPT 967.4M
- IPO Year
- REAX N/A
- EYPT 2005
- Fundamental
- Price
- REAX $3.44
- EYPT $11.76
- Analyst Decision
- REAX Strong Buy
- EYPT Strong Buy
- Analyst Count
- REAX 3
- EYPT 5
- Target Price
- REAX $6.33
- EYPT $27.40
- AVG Volume (30 Days)
- REAX 1.5M
- EYPT 1.4M
- Earning Date
- REAX 10-30-2025
- EYPT 11-05-2025
- Dividend Yield
- REAX N/A
- EYPT N/A
- EPS Growth
- REAX N/A
- EYPT N/A
- EPS
- REAX N/A
- EYPT N/A
- Revenue
- REAX $1,617,846,000.00
- EYPT $51,898,000.00
- Revenue This Year
- REAX $52.77
- EYPT N/A
- Revenue Next Year
- REAX $19.10
- EYPT N/A
- P/E Ratio
- REAX N/A
- EYPT N/A
- Revenue Growth
- REAX 72.57
- EYPT 2.99
- 52 Week Low
- REAX $3.57
- EYPT $3.91
- 52 Week High
- REAX $6.61
- EYPT $14.91
- Technical
- Relative Strength Index (RSI)
- REAX 28.34
- EYPT 42.93
- Support Level
- REAX $3.86
- EYPT $11.15
- Resistance Level
- REAX $3.96
- EYPT $12.47
- Average True Range (ATR)
- REAX 0.17
- EYPT 0.68
- MACD
- REAX -0.02
- EYPT -0.08
- Stochastic Oscillator
- REAX 0.00
- EYPT 23.37
About REAX The Real Brokerage Inc.
The Real Brokerage Inc is a technology-powered real estate brokerage firm located in the United States and Canada. It has developed a proprietary transaction management and brokerage operations software called reZEN, which powers nearly all of its brokerage operations, enabling efficiency, automation, and flexibility by incorporating end-to-end transaction management, automated compliance and brokerage oversight, integrated payments and financial services, Leo CoPilot, and open API for customization. In addition, the company also offers mortgage brokering and title services. The company's operating segments are North American Brokerage, which derives key revenue, One Real Title, One Real Mortgage, and Real Wallet. Geographically, it derives key revenue from the United States.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.